Affordable Access

Access to the full text

Minimally invasive surgery and cancer: controversies part 1

Authors
  • Goldfarb, Melanie1
  • Brower, Steven2
  • Schwaitzberg, S. D.3
  • 1 Beth Israel Deaconess Medical Center, Boston, MA, USA , Boston (United States)
  • 2 Memorial Health University Medical Center, Savanna, GA, USA , Savanna (United States)
  • 3 Cambridge Health Alliance, Department of Surgery, Cambridge, MA, USA , Cambridge (United States)
Type
Published Article
Journal
Surgical Endoscopy
Publisher
Springer-Verlag
Publication Date
Jul 02, 2009
Volume
24
Issue
2
Pages
304–334
Identifiers
DOI: 10.1007/s00464-009-0583-3
Source
Springer Nature
Keywords
License
Green

Abstract

Perhaps there is no more important issue in the care of surgical patients than the appropriate use of minimally invasive surgery (MIS) for patients with cancer. Important advances in surgical technique have an impact on early perioperative morbidity, length of hospital stay, pain management, and quality of life issues, as clearly proved with MIS. However, for oncology patients, historically, the most important clinical questions have been answered in the context of prospective randomized trials. Important considerations for MIS and cancer have been addressed, such as what are the important immunologic consequences of MIS versus open surgery and what is the role of laparoscopy in the staging of gastrointestinal cancers? This review article discusses many of the key controversies in the minimally invasive treatment of cancer using the pro–con debate format.

Report this publication

Statistics

Seen <100 times